NCT05079568
A Study to Evaluate the Safety and Tolerability of Virtual Reality to Treat Gastroparesis
A Pilot Study to Assess the Safety, Tolerability and Efficacy of Virtual Reality for the Treatment of Gastroparesis
Mayo Clinic·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov →Study focus
- Disease/Condition
- Gastroparesis
- Drug/Device/Intervention
- Oculus Go VR headset
- Study type
- Interventional
- Intervention type
- device
Sponsor & location
- Primary sponsor
- Mayo Clinic
- Location
- Jacksonville,Jacksonville, United States of America
Timeline & enrollment
- Phase
- N/A
- Start date
- Oct 01, 2021
- End date
- Dec 01, 2022
- Enrollment
- 30 participants
Primary outcome
Patient-reported adverse events
Summary
The purpose of this study is to determine if virtual reality therapy is safe and tolerable in
 treating gastroparesis.
ICD-10 classifications
Attention to gastrostomyGastrostomy statusOther gastritisGastritis, unspecifiedGastric diverticulum
Data source
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT05079568
- Type
- Device Trial
About this record
Access comprehensive clinical trial information for NCT05079568 through Pure Global AI's free database. This phase not specified trial is sponsored by Mayo Clinic and is currently Recruiting. The study focuses on Gastroparesis. Target enrollment is 30 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.